Skip to main
ELMD
ELMD logo

Electromed (ELMD) Stock Forecast & Price Target

Electromed (ELMD) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Electromed Inc. demonstrated strong financial performance with a notable 14.8% growth in homecare revenue, reaching $14.1 million, attributed to increased sales representative productivity and effective demand generation strategies. The company's commitment to expanding its presence in both the domestic homecare market and select international regions underscores its growth potential, complemented by a strategic push into the acute care sector. Although SG&A expenses increased by 17.2% due to investments in sales, marketing, and reimbursement, these expenses are seen as necessary for sustaining long-term growth and enhancing overall market presence.

Bears say

Electromed Inc. faces significant challenges that contribute to a negative outlook for its stock, including margin compression, competitive headwinds, and decreased sales representative productivity. The company's recent decline in share price from a high of $35.43 to approximately $18 indicates investor concern regarding these underlying issues. Furthermore, despite clinical studies supporting the effectiveness of its SmartVest Airway Clearance System, these operational hurdles could hinder Electromed's ability to capitalize on market opportunities and achieve sustainable financial growth.

Electromed (ELMD) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Electromed (ELMD) Forecast

Analysts have given Electromed (ELMD) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Electromed (ELMD) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Electromed (ELMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.